We developed an in situ assay system to simultaneously monitor intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i, fura 2 as indicator) and nitric oxide (NO) levels [4,5-diaminofluorescein as probe] in the intact endothelium of small bovine coronary arteries by using a fluorescent microscopic imaging technique with highspeed wavelength switching. Bradykinin (BK; 1 M) stimulated a rapid increase in [Ca 2ϩ ]i followed by an increase in NO production in the endothelial cells. The protein tyrosine phosphatase inhibitor phenylarsine oxide (PAO; 10 M) induced a gradual, small increase in [Ca 2ϩ ]i and a slow increase in intracellular NO levels. Removal of extracellular Ca 2ϩ and depletion of Ca 2ϩ stores completely blocked BKinduced increase in NO production but had no effect on PAO-induced NO production. However, a further reduction of [Ca 2ϩ ]i by application of BAPTA-AM or EGTA with ionomycin abolished the PAO-induced NO increase. These results indicate that a simultaneous monitoring of [Ca 2ϩ ]i and intracellular NO production in the intact endothelium is a powerful tool to study Ca 2ϩ -dependent regulation of endothelial nitric oxide synthase, which provides the first direct evidence for a permissive role of Ca 2ϩ in tyrosine phosphorylationinduced NO production. endothelium-derived relaxing factor; signal transduction; protein kinase; coronary circulation; heart NITRIC OXIDE SYNTHASES (NOSs) comprise a family of three mammalian gene products that each possess an NH 2 -terminal heme-containing oxygenase domain and a COOH-terminal flavin-containing reductase domain, bridged by a canonical CaM-binding polypeptide (33 
NITRIC OXIDE SYNTHASES (NOSs) comprise a family of three mammalian gene products that each possess an NH 2 -terminal heme-containing oxygenase domain and a COOH-terminal flavin-containing reductase domain, bridged by a canonical CaM-binding polypeptide (33) . /CaM to these enzymes (35) . In contrast, inducible NOS (iNOS) binds to CaM with such high affinity that it is already maximally activated at the Ca 2ϩ concentrations within resting cells (32) . These different regulatory mechanisms determine the NOS activity in response to various physiological or pathological stimuli, thereby participating in the control of a variety of cell functions (1) .
Endothelium-derived nitric oxide (NO) contributes to cardiovascular homeostasis through its profound effects on blood pressure, vascular remodeling, platelet aggregation, and angiogenesis (15) . It is well known that for some agonists, such as acetylcholine (29) and bradykinin (BK) (36) , a rise in intracellular Ca 2ϩ is necessary for NO production. However, recent studies indicated that shear stress (9, 30) , isometric contraction (10) , tyrosine phosphatase inhibitors (9, 28, 30) , IGF-I (34), estrogen (5) , and insulin (25) activate eNOS in isolated vessel preparations or in cultured cells in the absence of a change in [Ca 2ϩ ] i . These Ca 2ϩ -insensitive responses are blocked by tyrosine kinase inhibitors. It thus appears that eNOS activity is also regulated by a Ca 2ϩ -independent mechanism. However, purified eNOS and broken endothelial cell preparations containing eNOS are unable to produce NO in the absence of Ca 2ϩ in the reaction mixtures (14, 23) . The reason for these apparent conflicting findings remains unknown. It is possible that an alternative signaling pathway for eNOS activation exists that does not require elevation of [Ca 2ϩ ] i but is dependent on a basal level of [Ca 2ϩ ] i . This hypothesis can be tested by simultaneous measurements of endothelial [Ca 2ϩ ] i and NO production. Recently, a novel fluorescent NO indicator, 4,5-diaminofluorescein (DAF-2) diacetate (DAF-2 DA), was developed (18) and applied to in situ monitoring of NO production (2, 37) . This dye can readily enter the cells and be hydrolyzed by cytosolic esterases to DAF-2 that is trapped inside the cells. The fluorescent chemical transformation of DAF-2 is based on the reactivity of the aromatic vicinal diamines with NO in the presence of dioxygen. This N-nitrosation of DAF-2 produces a highly green-fluorescent triazole form, DAF-2T. Because this nitrosation reaction is essentially irreversible (20) , DAF-2 fluorescence reflects a sum total of NO production. Thus this dye can be used to monitor NO production in response to different stimuli. In the present study, we combined DAF-2 fluorescent microscopic imaging with fura 2 fluorescence measurements to monitor simultaneous changes in accumulating intracellular NO levels and [Ca 2ϩ ] i in the intact endothelium of freshly dissected small bovine coronary arteries. This in situ simultaneous assay of [Ca 2ϩ ] i and NO production in endothelial cells circumvents the problems encountered with cultured endothelial cells, in which the expression of cell surface receptors, ion channels, and intracellular signaling mechanism might be changed because of enzymatic, mechanical, or culturing treatments (19, 22) . Using this assay system, we examined the simultaneous responses of [Ca 2ϩ ] i and NO production to different agonists or stimuli to determine the [Ca 2ϩ ] i dependence or -independence of eNOS and to explore the mechanisms regulating eNOS activity in the endothelium of coronary arteries.
MATERIALS AND METHODS
Isolated small coronary artery preparation and dye loading. Fresh bovine hearts were obtained from a local abattoir. Small coronary arteries (400-to 600-m ID) were prepared as we described previously (37) . In brief, the left ventricular wall was rapidly dissected and immersed in ice-cold modified Hanks' buffered saline solution containing (in mM) 137 NaCl, 5.4 KCl, 4.2 NaHCO 3, 3 Na2HPO4, 0.4 KH2PO4, 1.5 CaCl2, 0.5 MgCl2, 0.8 MgSO4, 10 glucose, 10 HEPES, pH 7.4. This myocardial section was transported immediately to a dissection station, and small intramural coronary arteries from the left anterior descending artery were carefully dissected and placed in cold Hanks' buffer and then transferred to a 0.9-mm microdissecting dish filled with Sylgard (World Precision Instruments) immersed in ice-cold Hanks' buffer. The arterial segment was cut open along its longitudinal axis and pinned onto the Sylgard with the lumen side upward. Care was taken not to disrupt the endothelium. Four additional supportive pins were placed around the lumen-opened artery with the top ends 1.2 mm over the arterial endothelium. After the artery was fixed, the 0.9-mm dish was put into a recording chamber with the vessel lumen side downward facing the objective of an inverted microscope. A 1.2-mm space between the arterial endothelium and the glass bottom of the recording chamber was made by the supportive pins. This kept the artery endothelium from direct contact with glass bottom and allowed the solution a free passage. The recording chamber was filled with Hanks' buffer. After a 30-min equilibration, the bath solution was exchanged with 1 ml of Hanks' buffer containing DAF-2 DA (10 M; Sigma), fura 2-AM (10 M; Molecular Probes), Pluronic F-127 (0.025%; Molecular Probes), and BSA (0.05%), and the artery was incubated in this loading solution for 40 min at room temperature. The arteries were then rinsed three times with Hanks' buffer to remove extracellular fura 2-AM and DAF-2 DA, and an additional 30 min were allowed for intracellular deesterification of fura 2-AM to fura 2.
In situ simultaneous measurement of [Ca 2ϩ ]i and NO production in intact endothelium of coronary arteries. [Ca 2ϩ ]i and NO fluorescent imaging analysis was performed with a modification of the method used by Li and van Breemen (21) for [Ca 2ϩ ]i measurement in intact endothelium of rabbit cardiac valve, with a combination of DAF-2 and Ca 2ϩ assay through the high-speed excitation and emission wavelength switching systems. After dye loading, the chamber solution was kept at 37°C by a temperature control system (Warner Instruments, Hamden, CT). The chamber was mounted on an inverted microscope with epifluorescence attachments (Diaphot 200; Nikon, Tokyo, Japan) so that a ϫ20 phase/fluor objective (Nikon Diaphot) was focused on the endothelium and individual endothelial cells were visualized. The excitation light from a xenon lamp was filtered to provide wavelengths of 340 Ϯ 10, 380 Ϯ 10 (for fura 2), and 480 Ϯ 20 (for DAF-2) nm with a high-speed wavelength switcher (Lambda DG-4; Sutter, Novato, CA). Emission light from endothelial cells was passed through a dichroic mirror (500 nm) and through an emission filter of 510 Ϯ 20 nm for fura 2 or 535 Ϯ 25 nm for DAF-2 with a high-speed rotating filter wheel (Lambda 10-2; Sutter). The fluorescence images were recorded by a digital camera (SPOT RT Monochrome; Diagnostic Instruments). Metafluor imaging and analysis software (Universal Imaging) was used to acquire, digitize, and store the images and data for off-line processing and statistical analysis. The autofluorescence of the unloaded endothelium was minimal, and the background images were obtained from a focal plane 1 mm away from the endothelium. The relative fluorescence intensities for fura 2 (128 Ϯ 38 for F380) and DAF-2 (147 Ϯ 42) are quantitatively comparable. When the endothelium was only loaded with fura 2-AM, no signal at 480/535 nm (for NO imaging) was detected. In contrast, when the endothelium was only loaded with DAF-2 DA, no detectable signal could be recorded at 340/510-and 380/ 510-nm wavelengths (for Ca 2ϩ imaging) (data not shown). To reduce photobleaching of these fluorescent dyes, images with excitation of 340 and 380 nm for Ca 2ϩ were acquired at 2-s intervals, and images at excitation of 480 nm for NO were acquired at 10-s intervals. F340/F380, a fluorescence ratio of excitation at 340 nm to that at 380 nm, was determined after background subtraction, and [Ca 2ϩ ]i was calculated by using the following equation (13)
where Kd for the fura 2-Ca 2ϩ complex is 224 nM; R is the fluorescence ratio (F340/F380); Rmax and Rmin are the maximal and minimal fluorescence ratios measured by addition of 10 M of Ca 2ϩ ionophore ionomycin to Ca 2ϩ -replete (2.5 mM CaCl2) solution and Ca 2ϩ -free (5 mM EGTA) solution, respectively; and ␤ is the fluorescence ratio at 380-nm excitation determined at Rmin and Rmax, respectively (13) .
Because there was no significant change in baseline fluorescence during a 60-min experiment, we expressed the intracellular NO production as relative fluorescence (f), which is the net increment of DAF-2 fluorescence relative to its basal value (f ϭ ⌬F/F0 ϫ 1,000), where F is DAF-2 fluorescence intensity obtained during experiments and F0 is its basal fluorescence intensity.
Differential conversion of NO fluorescence intensity. Because NO does not dissociate from DAF-2 once this dye reacts with NO, the detected NO-sensitive fluorescence with DAF-2 primarily represents a cumulative amount of NO within the cells as described above. An obvious disadvantage of this method for continuous NO measurements is that the plateau area of the NO-DAF-2 fluorescence curve does not represent the actual NO concentration. In fact, the formation of this plateau mainly results from the termination of NO production within the cells. To more representatively show the features of NO-DAF-2 fluorescence and to accurately present the relationship between NO production and Ca 2ϩ concentration in the cells, we performed a differential conversion of time-dependent NO-DAF-2 fluorescence curve to calculate df/dt, which represents NO production rate. We plotted the converted df/dt against the reaction time and presented this curve with [Ca 2ϩ ] changes in parallel. We also calculated the area under the df/dt curve (AUC), which indicates the cumulative amount of NO in the cells.
We first performed regression analysis of the NO-DAF-2 fluorescence curve recorded during different stimuli to obtain a regression equation. A differential conversion was then undertaken based on the regression equation. For example, the NO-DAF-2 curve recorded during BK incubation was fitted with a sigmoidal four-parameter Gompertz growth model analyzed with SigmaPlot 5.0. An equation for BKinduced time-dependent change in fluorescence (f ) was described as follows f ϭ ae
where t is time, t 0 is time when BK is added, and a, b, and c are constants, which define the shape for a specific-fitting curve of BK response and can be calculated with the curve fitting program of SigmaPlot 5.0.
To obtain the NO production rate, df/dt, the differential conversion of Eq. 1 was performed with the following equation (6)
Statistical analysis. Data are presented as means Ϯ SE. Significant differences in mean values between and within multiple groups were examined by using ANOVA for repeated measures, followed by a Duncan multiple-range test. A value of P Ͻ 0.05 was considered statistically significant. [Ca 2ϩ ] i and NO production in intact endothelium of small bovine coronary arteries. Figure 1 shows representative images and recordings of simultaneously measured [Ca 2ϩ ] i and NO production in the intact endothelium of small coronary arteries. Figure 1A shows that the F 340 -to-F 380 ratio dramatically increased from 0.8 (green color) to 1.3 (red color) in 2 min with addition of BK (1 M) to the bath solution. The green DAF-2 fluorescence was also simultaneously stimulated by BK. As shown in Fig. 1B , a digitized on-line recording of [Ca 2ϩ ] i and DAF-2 fluorescence in this arterial endothelium preparation was also monitored throughout the experiment. A plateau of DAF-2 fluorescence was observed. As discussed above, this plateau was formed because of the termination of NO production, which was not associated with a constant association and dissociation of NO and DAF-2. To more accurately present this feature of NO/DAF-2 fluorescence, a differential conversion was performed, and data are presented in Fig. 1C ; df/dt represents the production rate for NO. From this plot, a peak response of [Ca 2ϩ ] i to BK was observed within 2 min and the rise of [Ca 2ϩ ] i decreased gradually by 50% and was sustained for 20 min. However, NO production, as shown by df/dt, reached maximum at 2 min of BK treatment and then stopped 7 min after BK treatment. The sustained Ca 2ϩ increase seems not to influence NO production induced by BK.
RESULTS

Simultaneous monitoring of
Confirmation of location and specificity of detected [Ca 2ϩ ] i and NO level. When the endothelium of coronary arteries was gently scraped after loading, a dark image (Ͻ5% fluorescence intensity compared with intact endothelium) was obtained, indicating that little fluorescence signal was derived from the underlying smooth muscle layer in this preparation. In contrast to the intact endothelium (Fig. 1) , removal of the endothelium abolished the BK-induced increase in [Ca 2ϩ ] i and DAF-2 fluorescence (Fig. 2) .
To exclude the interaction of Ca 2ϩ and NO signals in our assay, we tested whether alterations of Ca 2ϩ signals influence NO measurement and vice versa. As shown in Fig. 3A , an NO donor, deta NONOate (100 M), was added to directly increase intracellular NO. Because deta NONOate releases NO directly, it should not have any effect on [Ca 2ϩ ] i . DAF-2 fluorescence time dependently increased during a 30-min incubation with deta NONOate, whereas no detectable change in fura 2 fluorescence ratio was observed. On the other hand, preincubation of the coronary arteries with the NOS inhibitor nitro-L-arginine methyl ester (L-NAME; 100 M, preincubated for 30 min) substantially inhibited the BK-induced increase in total NO production by ϳ72% (112 Ϯ 45 AUC of L-NAME vs. 412 Ϯ 57 AUC of BK control; P Ͻ 0.05, n ϭ 6) but did not alter BKinduced increase in [Ca 2ϩ ] i (568 Ϯ 43 nM in L-NAMEtreated cells vs. 540 Ϯ 56 nM in BK control; P Ͼ 0.05, n ϭ 6). Similar inhibitory effects of L-NAME on NO production also occurred when the vessels were loaded only with DAF-2 DA (124 Ϯ 39 AUC of L-NAME vs. 428 Ϯ 62 AUC of BK control; P Ͻ 0.05, n ϭ 6). It seems that L-NAME did not completely block NO production in this preparation. In previous studies, we and others (11, 27, 38) also confirmed that L-NAME could not completely block NO increase during different stimuli. However, preincubation of the arteries with both carboxy-PTIO (100 M), an intracellular NO scavenger (26) , and L-NAME (100 M) for 30 min totally abolished the BK-induced increase in NO production but did not alter BK-induced increase in [Ca 2ϩ ] i (Fig. 3B) 
Effects of phenylarsine oxide on [Ca 2ϩ ] i and NO production in coronary endothelium. The protein tyrosine phosphatase inhibitor phenylarsine oxide (PAO) activates eNOS in the preparations of endothelial cells in a Ca
2ϩ
-independent manner (9, 30 ). Therefore, we tested whether this compound also stimulates NO production without an increase in [Ca 2ϩ ] i in the intact endothelium of coronary arteries. As shown in Fig. 5A , PAO (10 M) induced a gradual, slow increase in [Ca 2ϩ ] i from 110 Ϯ 17 nM to a maximum of 198 Ϯ 31 nM 7-8 min after its addition, which was then sustained throughout the experimental period (n ϭ 6). PAO also induced a gradual, slow increase in NO production in the endothelial cells, which continued with an increasing production rate (df/dt) as late as 30 min after addition of PAO (Fig. 5A) ] i increase but had no effect on PAO-induced NO accumulation (502 Ϯ 98 AUC of TSG ϩ EGTA vs. 480 Ϯ 69 AUC of PAO control in 30 min; P Ͼ 0.05, n ϭ 6) and NO production rate (Fig. 5B) .
Inhibition of PAO-induced NO production by L-NAME and tyrosine kinase inhibitor. To confirm that PAOinduced NO production is associated with protein tyrosine phosphorylation, the effects of the tyrosine kinase inhibitor erbstatin A were examined. As shown in Fig. 6 , preincubation of coronary arteries with erbstatin A substantially reduced PAO-induced NO production but was without effect on the small increase in [Ca 2ϩ ] i in response to PAO. Similarly, the NOS inhibitor L-NAME did not alter PAO-induced increase in [Ca 2ϩ ] i but significantly inhibited PAO-induced NO production.
Permissive role of Ca 2ϩ in PAO-induced NO production. As shown in Fig. 5B , PAO still increased NO production in coronary endothelium, in which Ca 2ϩ stores were depleted by 1 M TSG and Ca 2ϩ influx was abolished by the use of Ca 2ϩ -free solution containing 1 mM EGTA. This NO production by enhancing tyrosine phosphorylation does not seem to require Ca 2ϩ as a trigger. However, when [Ca 2ϩ ] i was maximally decreased to almost 0 nM by preincubation of the arterial endothelium with Ca 2ϩ -free buffer plus EGTA (1 mM) in combination with the cell-permeant intracellular Ca 2ϩ chelator BAPTA-AM (100 M) for 30 min, PAO could no longer induce NO production (Fig. 7) . Similarly, complete removal of intracellular Ca 2ϩ by incubation of the endothelium with Ca 2ϩ -free solution containing EGTA (1 mM) and Ca 2ϩ ionophore ionomycin (10 M) (to remove all Ca 2ϩ inside the cells) abolished the PAO-induced NO production (8.9 Ϯ 7.4 AUC of ionomycin ϩ EGTA vs. 480 Ϯ 69 AUC of PAO control in 30 min; P Ͻ 0.05, n ϭ 6).
To rule out the possibility that chelation or removal of intracellular free Ca 2ϩ nonspecifically damages cell function and to determine a threshold value of [Ca 2ϩ ] i necessary for PAO to stimulate NO production, we performed experiments to restore intracellular Ca 2ϩ by replacing the bath solution with different CaCl 2 concentrations. These results are shown in Fig. 7 . PAO had no effect on [Ca 2ϩ ] i and NO production when the endothelium was incubated in Ca 2ϩ -free solution with EGTA plus BAPTA-AM for 30 min. After the bath solution was replaced with Hanks' buffer containing CaCl 2 , the PAO-induced NO response was restored, starting at 50 M CaCl 2 . The PAO-induced NO response was fully restored when [Ca 2ϩ ] i reached ϳ80 nM with extracellular CaCl 2 of 100 M. However, extracellular CaCl 2 at 10 M could not induce any restoration of PAO-induced NO response, although it increased intracellular Ca 2ϩ to 20 nM.
DISCUSSION
By simultaneously monitoring [Ca 2ϩ ] i and NO levels in the intact endothelium of small coronary arteries, the present study provides direct evidence that eNOS can be activated by agonist-induced increases in [Ca 2ϩ ] i and by enhanced phosphorylation of the enzyme associated with inhibition of tyrosine phosphatase or stimulation of tyrosine kinase. Although the activation of eNOS by phosphorylation does not require a large increase in [ -dependent enzyme (1, 12) , recent studies indicated that eNOS also produces NO independently of intracellular Ca 2ϩ (5, 9, 10, 25, 28, 30, 34) . The present study was designed to further determine the role of intracellular Ca 2ϩ in the regulation of eNOS activity and to explore the mechanism by which Ca 2ϩ activates or modulates NO production via eNOS. In these experiments, we developed an imaging analysis to simultaneously monitor alterations of [Ca 2ϩ ] i with fura 2 and the total amount of intracellular NO with DAF-2 in the intact endothelium of freshly dissected small coronary arteries. This technique allows us to directly determine the relationship between [Ca 2ϩ ] i and NO levels in the endothelium and to continuously observe the role of Ca 2ϩ in the activation or modulation of NOS activity. By an analysis of the time course for the parallel changes in [Ca 2ϩ ] i and NO levels in endothelial cells, the mechanism mediating the effect of Ca 2ϩ on NOS activity can be explored. To validate this assay system, we performed a series of experiments to determine the possible influences of Ca 2ϩ and NO signals on each other. First, by using excitation and emission wavelength switching systems, we successfully recorded Ca 2ϩ and NO fluorescence images "simultaneously." These images from representative cells or areas were digitized and stored for offline data analysis (Fig. 1) . A response curve of both Ca 2ϩ and NO clearly exhibited dynamic changes in [Ca 2ϩ ] i and NO levels in response to stimuli such as BK and PAO.
By separately loading fura 2-AM or DAF-2 DA into the endothelial cells in coronary arteries, we demonstrated that there was no cross signal at the corresponding wavelength region for DAF-2 or fura 2 fluorescence, respectively. Because fura 2 has a broad emission signal that significantly overlaps the excitation region of DAF-2, there is a concern that the fura 2 emission may excite DAF-2 to produce fluorescence, thereby resulting in an artifact in Ca 2ϩ measurement. In general, however, the ratio of emitted fluorescence intensity to excitation light intensity is between 1:10,000 and 1:1,000,000 (31); it is impossible for the fura 2 emission to excite DAF-2 to produce detectable fluorescence because the fura 2 emission intensity is not comparable to DAF-2 excitation light intensity. To further exclude the interaction of two fluorescence signals, we first tested the effects of the NO donor deta NONOate on [Ca 2ϩ ] i production. It was found that deta NONOate increased the NO signal, but it had no effect on Ca 2ϩ signal, suggesting that DAF-2 fluorescence is without influence on Ca 2ϩ signal in this assay. On the other hand, the NOS inhibitor L-NAME inhibited the BK-induced increase in NO production by ϳ70% but did not alter BK-induced increase in [Ca 2ϩ ] i . When a combination of both L-NAME and the intracellular NO scavenger carboxy-PTIO was used, the BK-induced increase in DAF-2 fluorescence was completely abolished but Ca 2ϩ response to BK was not altered, suggesting that NO signal also has no influence on Ca 2ϩ signal. In light of these results, we have confidence that these assays can simultaneously detect both [Ca 2ϩ ] i and NO production in situ in endothelial cells without interference with each other and can reliably determine the role of Ca 2ϩ in the regulation of NOS activity. This in situ measurement of [Ca 2ϩ ] i and NO levels in the intact endothelium of freshly dissected coronary arteries excludes the possible influences of various experimental manipulations on NOS activity in isolated or cultured endothelial cells or purified enzymes. Therefore, the results from the intact endothelium obtained from the present experiments may more precisely represent the behavior of NOS and Ca 2ϩ within the endothelium under physiological conditions.
Role of Ca 2ϩ in regulation of eNOS activity. BK is a classic Ca 2ϩ -dependent activator of eNOS (4, 36) . In the present study, it produced a rapid and simultaneous increase in intracellular Ca 2ϩ and intracellular NO. Although the rise in [Ca 2ϩ ] i in response to BK was sustained after a peak increase, it seems that this sustained [Ca 2ϩ ] i increase is not responsible for activation of NOS, because the increase in DAF-2 fluorescence stopped 5 min after BK treatment. Given that a rapid peak increase of [Ca 2ϩ ] i is primarily determined by intracellular Ca 2ϩ mobilization (16, 17) , this BKinduced NOS activation may be largely dependent on Ca 2ϩ release from the intracellular stores. These results are consistent with the view that eNOS activity is activated by intracellular Ca 2ϩ mobilization and subsequent binding of Ca 2ϩ /CaM to NOS and displacement from caveolin-1 (7, 24) .
The tyrosine phosphatase inhibitor PAO also activated NO production in the endothelium. The PAOinduced NOS activation was not associated with increase in [ stores had no effect on PAO-induced increase in NO levels in the endothelium. This suggests that inhibition of dephosphorylation of tyrosine by PAO directly activates eNOS in endothelial cells independently of a Ca 2ϩ increase. Previous studies also demonstrated that PAO-induced NOS activation is associated with tyrosine phosphorylation but not with a Ca 2ϩ increase in these cells (9, 30) . Indeed, the tyrosine kinase inhibitor erbstatin A blocked PAO-induced increase in NO production in the endothelium in our experiments, further supporting the role of tyrosine phosphorylation in the activation of eNOS. However, this Ca 2ϩ -independent eNOS activation conflicts with published results that eNOS did not have Ca 2ϩ -independent activity in broken cell preparations or as a purified enzyme (14, 23) . In this regard, PAO-induced NOS activation was even reported also to depend on Ca 2ϩ increase in cultured endothelial cells (8) . It appears that intracellular Ca 2ϩ may also participate in the regulation of eNOS activity induced by PAO, even though it may not directly mediate eNOS activation.
To ] i to ϳ80 nM, PAO-induced NO production was substantially restored. These results suggest that [Ca 2ϩ ] i may be a prerequisite of PAO-induced NO production, despite the fact that it may not directly trigger eNOS activation by PAO. This view is further supported by our findings that complete removal of [Ca 2ϩ ] i with the calcium ionophore ionomycin and EGTA blocked PAO-induced NOS activation. As Brouet et al. (3) pointed out recently, the term "Ca 2ϩ -independent activation of eNOS" may be misleading and the Ca 2ϩ dependence of eNOS is an important feature of the enzyme. However, the mechanisms mediating the actions of intracellular Ca 2ϩ in NOS activation may be different depending on the stimuli. It may directly mediate the activation of eNOS in response to classic Ca 2ϩ -dependent stimulators such as BK, acetylcholine, and Ca 2ϩ ionophore A-23198 (29, 36) . It may also play a permissive role in the activation of eNOS induced by other stimuli such as shear stress, inhibition of tyrosine dephosphorylation, activation of tyrosine kinase, IGF-I, and insulin (9, 10, 25, 30, 34) .
In summary, a simultaneous assay system for [Ca 2ϩ ] i and NO production was used to determine the role of Ca 2ϩ in the activation of NOS in the intact endothelium from small coronary arteries. Two Ca 2ϩ -dependent mechanisms were found to regulate the NOS activity in this in situ preparation. An increase in intracellular Ca 2ϩ mediates the activation of eNOS in response to BK, and basal [Ca 2ϩ ] i is a prerequisite for activation of eNOS by tyrosine phosphorylation.
